- Case report
- Open Access
- Open Peer Review
Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: a case report
Journal of Medical Case Reportsvolume 10, Article number: 113 (2016)
Immunoglobulin G4-related disease is characterized by infiltration of immunoglobulin G4-positive plasmacytes in various organs. The radiological findings of lung involvement of immunoglobulin G4-related disease include hilar and mediastinal lymphadenopathies, thickness of bronchovascular bundles, peribronchovascular consolidation, and lung nodules. Although a pathological approach is needed to diagnose immunoglobulin G4-related disease, it is ordinarily diagnosed by biopsy from one lesion even if there are multiple lesions. We reported a rare case of the coexistence of immunoglobulin G4-related disease and lung cancer in the same lung nodule.
A 72-year-old Japanese man visited our hospital for evaluation of a nodular shadow in the middle lobe of his right lung that was seen on chest radiograph and computed tomography scan. An abdominal computed tomography scan showed a tumefactive lesion in his anterior sacral spine. Blood examinations revealed high serum immunoglobulin G4 concentration at 346 mg/dl, renal dysfunction, and anemia. He underwent right upper lobectomy and regional lymph node dissection. Pathologic findings of the lung nodule showed lepidic pattern adenocarcinoma with infiltration of immunoglobulin G4-positive plasma cells and obliterative phlebitis.
To date, there have been only few reports on the coexistence of immunoglobulin G4-related disease and lung cancer; here, we report such a rare case. Histologic examination should be considered in cases of suspicious immunoglobulin G4-related disease appearing in a lung nodule.
IgG4-related disease is characterized by infiltration of IgG4-positive plasmacytes in various organs . The clinical manifestations include autoimmune pancreatitis, Riedel’s thyroiditis, tubulointerstitial nephritis, Mikulicz’s disease, and retroperitoneal fibrosis; histologic findings show lymphoplasmacytic infiltration, obliterative phlebitis, and storiform fibrosis . The patterns of lung involvement of IgG4-related disease include hilar and mediastinal lymphadenopathies, thickness of bronchovascular bundles, peribronchovascular consolidation, and lung nodules. Here, we report a rare case of lung cancer coexisting with IgG4-related disease in the same lung nodule. It is interesting that the cancer cells and IgG4-positive plasma cells coexisted in the same nodule, rather than being just a complication.
A 72-year-old Japanese man, who had no underlying disease, visited our hospital because of a nodular lung shadow that was detected during an annual health examination. He did not have any respiratory symptoms, such as cough, sputum production, and dyspnea. A chest radiograph showed a small nodular shadow in the middle lobe of his right lung (Fig. 1a). A chest computed tomography (CT) scan showed a 20-mm spiculated nodule with pleural indentation in the upper lobe of his right lung (Fig. 1b), but no hilar and mediastinal lymphadenopathies were seen. An abdominal CT scan showed a tumefactive lesion in his anterior sacral spine and left hydronephrosis. His laboratory findings on admission were 10.8 g/dl hemoglobin, 27.1 mg/dl blood urea nitrogen, 2.04 mg/dl creatinine and 0.53 mg/dl C-reactive protein. His IgG and IgG4 concentration was at 2407 mg/dl and 346 mg/dl (normal range, 4.8 to 105 mg/dl). Tumor markers, such as carcinoembryonic antigen (CEA) and cytokeratin fragment (CYFRA) 21–1, were within normal range.
An 18F-fluorodeoxyglucose-positron emission tomography (18F-FDG-PET) scan revealed high accumulation in his lung nodule, with maximum standardized uptake value (SUV) of 2.7 in the early phase and 3.3 in the delayed phase. His hilar and mediastinal lymph node showed high 18F-FDG accumulation with maximum SUV of 2.5 in the early phase and 2.3 in the delayed phase (Fig. 2a). The tumefactive lesion in his anterior sacral spine also showed high 18F-FDG accumulation, with maximum SUV of 4.0 in the early phase and 4.5 in the delayed phase (Fig. 2b). Abnormal accumulation in other organs was not observed on 18F-FDG-PET. A transbronchial biopsy with bronchoscopy was performed, which revealed carcinoma cells on cytology. He was diagnosed with lung cancer at T1bN0M0, stage 1A; this was suspected to be related to IgG4-related retroperitoneal fibrosis.
He underwent a right upper lobectomy and regional lymph node dissection. He was discharged on day 10 after lung surgery without any complications. Pathologic findings of the resected lung nodule showed lepidic pattern adenocarcinoma with coexisting infiltration of IgG4-positive plasma cells (Fig. 3a), with an IgG4 to IgG ratio of more than 40 % (Fig. 3b, c). Storiform fibrosis was not seen; however, obliterative phlebitis and nonspecific fibrosis were shown in his lung nodule (Fig. 3d). In his right hilar lymph node which showed positive findings of the 18F-FDG-PET scan, infiltration of IgG4-positive plasma cells with storiform fibrosis were seen (Fig. 3e, f). All sampled lymph nodes were negative for cancer cells. Distant metastasis was not observed. At 5 years after operation, he remained free from recurrence of lung cancer.
IgG4-related disease comprises elevated serum IgG4 concentrations and pathologic findings of lymphoplasmacytic infiltration of IgG4-positive plasma cells with storiform fibrosis and obliterative phlebitis in various organs . IgG4-related disease may involve multiple organs and present as autoimmune pancreatitis, Mikulicz’s disease, Riedel’s thyroiditis, retroperitoneal fibrosis, and multifocal fibrosclerosis. Although IgG4 plays a key role in the pathogenesis of the disease, the mechanisms of IgG4 elevation are not understood. It has been speculated that T cells are associated with pathogenesis, because many CD4 T cells are seen at sites of inflammation in IgG4-related disease .
Lung involvement of IgG4-related disease often affects the interstitium, airways, mediastinum, and pleura . Common radiologic findings include hilar and mediastinal lymphadenopathies, thickness of bronchovascular bundles, peribronchovascular consolidation, and lung nodules . Fujinaga et al. reported that thoracic abnormalities on CT included hilar and mediastinal lymphadenopathies in 78 % of cases; nodular lesions, 3 to 26 mm in size, in 39 % of cases; bronchial wall thickening in 30 % of cases; interlobular thickening in 15 %; and consolidation in 4 % .
18F-FDG-PET can be used for diagnosis of malignancies because of its capacity to detect metabolic activity in malignant cells. IgG4-related disease has also been reported to demonstrate high 18F-FDG uptake in diseased sites . Although the value of SUV may increase in both inflammatory and malignant lesions, PET-CT remains a useful test to identify the extent of a lesion in IgG4-related disease.
The present case showed retroperitoneal fibrosis, lymphadenopathies, and lung nodules with elevated serum IgG4 concentration. Nodular shadow of the lung was also reported to be a major manifestation in 31 to 46 % of IgG4-related lung diseases [5, 7, 8]. In this case, pathologic examination confirmed the coexistence of lung adenocarcinoma and IgG4-positive plasma cells with obliterative phlebitis in a lung nodule. Previous reports suggested that patients with IgG4-related disease had a higher incidence of malignancies, including lung cancer, pancreatic cancer, colon cancer, and malignant lymphoma . Inoue et al. reported a similar case of lung cancer and IgG4-related disease . The present case is the second report that cancer cells and IgG4-positive plasma cells coexisted with obliterative phlebitis in the same nodule, rather than being just a complication. It is suggested that the production of IgG4 plasma cells may be a response to unknown antigens. Further research is needed to investigate the pathogenesis of IgG4-related disease.
We reported a rare case of lung cancer coexisting with IgG4-related disease in the same lung nodule. Pathologic correlation by bronchoscopy and/or surgery should be considered in cases of suspicious IgG4-related disease appearing in a lung nodule.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
18F-fluorodeoxyglucose positron emission tomography
standardized uptake value
Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385(9976):1460–71.
Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–92.
Campbell SN, Rubio E, Loschner AL. Clinical review of pulmonary manifestations of IgG4-related disease. Ann Am Thorac Soc. 2014;11(9):1466–75.
Matsui S, Hebisawa A, Sakai F, Yamamoto H, Terasaki Y, Kurihara Y, et al. Immunoglobulin G4-related lung disease: clinicoradiological and pathological features. Respirology. 2013;18(3):480–7.
Fujinaga Y, Kadoya M, Kawa S, Hamano H, Ueda K, Momose M, et al. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol. 2010;76(2):228–38.
Kitada M, Matuda Y, Hayashi S, Ishibashi K, Oikawa K, Miyokawa N, et al. IgG4-related lung disease showing high standardized uptake values on FDG-PET: report of two cases. J Cardiothorac Surg. 2013;8:160.
Inoue D, Zen Y, Abo H, Gabata T, Demachi H, Kobayashi T, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology. 2009;251(1):260–70.
Matsui S, Taki H, Shinoda K, Suzuki K, Hayashi R, Tobe K, et al. Respiratory involvement in IgG4-related Mikulicz’s disease. Mod Rheumatol. 2012;22(1):31–9.
Yamamoto M, Takahashi H, Tabeya T, Suzuki C, Naishiro Y, Ishigami K, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22(3):414–8.
Inoue T, Hayama M, Kobayashi S, Oyaizu T, Nakazato Y, Honma K, et al. Lung cancer complicated with IgG4-related disease of the lung. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia. 2014;20 Suppl:474-7.
No funding was obtained for this report.
The authors declare that they have no competing interests.
HT was responsible for data collection, analysis, and interpretation, and drafting the manuscript. KT drafted and critically revised the manuscript. KK, SK, and NSA reviewed the manuscript, and helped to draft the manuscript. All authors read and approved the final manuscript.